Bayer
Genzyme, Bayer Schering Pharma AG, Germany Announce Start of Phase 3 Program with Alemtuzumab for Treatment of MS
By admin - Posted on September 27th, 2007
September 26, 2007 -- Genzyme Corporation (Nasdaq: GENZ) and Bayer Schering Pharma AG, Germany today announced that the first patient has been treated in the first of two planned Phase 3 trials examining the safety and efficacy of alemtuzumab for the treatment of multiple sclerosis (MS). » read more »
Medtronic, Bayer Diabetes Care Announce Alliance to Provide Blood Glucose Meter to Medtronic Patients Outside the United States
By admin - Posted on August 23rd, 2007
New Blood Glucose Meter to Provide Advanced Therapy Options for People with Diabetes Beginning in Canada and Europe
» read more »Latest stories
- Colin Powell Endorses Barack Obama for President: Video from this morning's appearance on Meet the Press
- Keating Economics
- Pelosi: The Legislation Has Failed But the Crisis Has Not Gone Away; We Must Work in a Bipartisan Way to Pass New Legislation
- Congressman Hoyer Statement Following Vote on Emergency Economic Stabilization Act
- Senator McCaskill Calls for Greater Accountability on Wall Street
- Senator Bob Casey Statement on Bailout Bill
- Senator Hillary Clinton Calls for Bipartisan Action on Economic Crisis
- Congress Passes Obama, Murkowski, Allen Bill to Ban Dangerous Mercury Exports
- Barack Obama Statement on Financial Plan Breakthrough
- Barack Obama Calls on VA Secretary to Provide Critical Data on Iraq and Afghanistan Veterans to Improve Veterans Services
Yes We Can
Yes We Can:
